The prognostic value of general laboratory testing in patients with COVID‐19-Reference-Cited by-同舟云学术

The prognostic value of general laboratory testing in patients with COVID‐19

Published:2020-12-13 Issue:2 Volume:35 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Lv Zhihua¹,Wang Wei²,Qiao Bin¹,Cui Xianghua¹,Feng Yong³⁴,Chen Lang⁴⁵,Ma Qingfeng⁶^ORCID,Liu Xinghui⁷

Affiliation:

1. Department of Clinical Laboratory Renmin Hospital of Wuhan University Wuhan China

2. Department of Clinical Laboratory Wuhan Fourth Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

3. Department of Medical Microbiology Wuhan University School of Basic Medical Sciences Wuhan China

4. Hubei Province Key Laboratory of Allergy and Immunology School of Basic Medical Sciences Wuhan University Wuhan China

5. Department of Immunology Wuhan University School of Basic Medical Sciences Wuhan China

6. Department of Clinical Laboratory Liyuan Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

7. Department of Clinical Laboratory Shanghai Gongli Hospital The Second Military Medical University Shanghai China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry, medical,Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.23668

Reference35 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Coronavirus disease (COVID‐2019) situation reports.https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019/situation‐reports. Accessed 15 February 2020.

3. General Office of the National Health Committee of China China Traditional Chinese Medicine Administration Office.Diagnosis and treatment plan of novel coronavirus pneumonia (seventh trial edition).2020.http://www.nhc.gov.cn/yzygj/s7652m/202003/a31191442e29474b98bfed5579d5af95.shtml. Accessed 11 March 2020.

4. Early transmission dynamics in Wuhan, China, of novel coronavirus‐infected pneumonia;Li Q;N Engl J Med,2020

5. The pro‐ and anti‐inflammatory properties of the cytokine interleukin‐6, BBA‐Mol;Scheller J;Cell Res,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-COVID-19: Hematological Factors Changes in Patients at Three-- time Intervals;Current Medicinal Chemistry;2024-07-09

2. A Comparative Study of Complete Blood Count (CBC) Tests in Children with COVID-19 in the Fifth Peak Compared to Other Peaks: A Cross-Sectional Study;The Open Public Health Journal;2024-06-06

3. A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2;Annals of Internal Medicine;2024-03

4. Transient low T3 syndrome in patients with COVID-19: a new window for prediction of disease severity;Frontiers in Endocrinology;2023-07-13

5. The bidirectional interaction of COVID-19 infections and lipoproteins;Best Practice & Research Clinical Endocrinology & Metabolism;2023-07